首頁 > 市場調查報告書 > 製藥

藥物開發開發業務受託機關

市場調查報告書

商品編碼

1608902

抗體契約製造市場：依產品類型、原料、最終用戶、地區分類

Antibodies Contract Manufacturing Market, By Product Type, By Source, By End User, By Geography

出版日期: 2024年11月25日 | 出版商:

Coherent Market Insights | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球抗體契約製造市場規模為196.1億美元，預計2031年將達383億美元，2024年至2031年複合年成長率為10%。

分析範圍		分析詳情
基準年	2023年	市場規模（2024年）	196.1億美元
實際資料	2019-2023	預測期	2024-2031
預測期複合年成長率（2024-2031）	10.00%	預計金額（2031年）	383億美元

圖：2024 年抗體契約製造市場佔有率（%），依地區分類

抗體是免疫系統 B 細胞產生的糖蛋白，用於中和細菌和病毒等病原體。抗體契約製造已成為生物技術和製藥公司採用的一種外包策略，用於商業規模開發和生產抗體。抗體開發所需的高研發投資、缺乏內部生產能力以及對核心能力的關注等因素正在推動對合約服務的需求。此外，細胞株工程和精製技術的不斷進步使契約製造製造商能夠提供大量高品質、穩定的抗體。因此，契約製造已牢固確立為全球公認的經營模式。

市場動態：

全球抗體契約製造市場受到生物製藥公司研發費用增加、單株抗體療法進步、對核心能力的日益關注以及非核心業務外包等因素的推動。然而，嚴格的監管流程、品質規範、技術轉移的潛在風險以及有限的產能等因素給業務的順利運作帶來了挑戰。同時，對生技改良藥和具有成本效益的抗體的需求不斷成長、分子工程工具的進步以及印度和中國等新興國家生技藥品行業的崛起，都帶來了巨大的市場機會。

本研究的主要特點

本報告對全球抗體契約製造市場進行了詳細分析，包括以2023年為基準年的預測期（2024-2031）的市場規模（十億美元）和年複合成長率（CAGR，%）。

它還揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察， FUJIFILM Diosynth Biotechnologies、Rentschler Biopharma SE、Charles River Laboratories、 Samsung Biologics、艾伯維合約製造公司、默克公司、BioNTech SE、安進公司、基因泰克、 Inc.、工業、Celerion、Avid Bioservices, Inc.

該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。

全球抗體契約製造市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。

透過用於分析全球抗體契約製造市場的各種策略矩陣，將有助於相關人員做出決策。

Report Coverage	Report Details
Base Year:	2023	Market Size in 2024:	19.61 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	10.00%	2031 Value Projection:	38.30 Bn

Antibodies are glycoproteins produced by B cells of the immune system to neutralize pathogens like bacteria and viruses. Contract manufacturing of antibodies has emerged as an outsourcing strategy adopted by biotech and pharmaceutical companies to develop and produce antibodies on a commercial scale. Factors such as hefty R&D investments required for antibody development, lack of in-house production capabilities, and focus on core competencies have boosted the demand for contract services. Moreover, continued advancements in cell line engineering and purification techniques have enabled contract manufacturers to provide high quality, consistent antibodies in large quantities. This has solidified antibodies contract manufacturing as an established business model worldwide.

Market Dynamics:

The global antibodies contract manufacturing market is driven by factors such as rising R&D expenditure of biopharmaceutical companies, advancement of monoclonal antibody therapeutics, growing focus on core competencies, and outsourcing of non-core activities. However, factors such as stringent regulatory processes and quality specifications, potential risks of technology transfer and capacity constraints pose challenges for smooth operations. On the brighter side, the market sees lucrative opportunities owing to increasing demand for bio-better and cost-effective antibodies, progress in molecular engineering tools, and emergence of developing biologics industry in countries like India and China.

Key Features of the Study:

This report provides in-depth analysis of the global antibodies contract manufacturing market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players Lonza Group, WuXi Biologics, Catalent, Inc., Fujifilm Diosynth Biotechnologies, Rentschler Biopharma SE, Charles River Laboratories, Samsung Biologics, AbbVie Contract Manufacturing, Merck KGaA, BioNTech SE, Amgen, Inc., Genentech, Inc., Takeda Pharmaceutical Company, Celerion, and Avid Bioservices, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global antibodies contract manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antibodies contract manufacturing market

Market Segmentation

By Product Type Insights (Revenue, USD Bn, 2019 - 2031)
- Monoclonal Antibodies
- Polyclonal Antibodies
- Others
By Source Insights (Revenue, USD Bn, 2019 - 2031)
- Mammalian Cells
- Microbial Systems
- Others
By End User Insights (Revenue, USD Bn, 2019 - 2031)
- Biopharmaceutical Companies
- Research Laboratories
- Others
Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Lonza Group
- WuXi Biologics
- Catalent, Inc.
- Fujifilm Diosynth Biotechnologies
- Rentschler Biopharma SE
- Charles River Laboratories
- Samsung Biologics
- AbbVie Contract Manufacturing
- Merck KGaA
- BioNTech SE
- Amgen, Inc.
- Genentech, Inc.
- Takeda Pharmaceutical Company
- Celerion
- Avid Bioservices, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Antibodies Contract Manufacturing Market, By Product Type
- Global Antibodies Contract Manufacturing Market, By Source
- Global Antibodies Contract Manufacturing Market, By End User
- Global Antibodies Contract Manufacturing Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Antibodies Contract Manufacturing Market, By Product Type, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Polyclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Antibodies Contract Manufacturing Market, By Source, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Mammalian Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Microbial Systems
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Antibodies Contract Manufacturing Market, By End User, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Research Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Antibodies Contract Manufacturing Market, By Region, 2019 - 2031, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Source, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Lonza Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
WuXi Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Catalent, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fujifilm Diosynth Biotechnologies
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Rentschler Biopharma SE
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Samsung Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AbbVie Contract Manufacturing
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
BioNTech SE
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amgen, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Genentech, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Takeda Pharmaceutical Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Celerion
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Avid Bioservices, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies